Clinical Trials
42 trialsROXI-CAT-I
Regeneron Pharmaceuticals
STAT-CAT
Brigham and Women's Hospital
HOME-PEK
Assistance Publique - Hôpitaux de Paris
MAGNOLIA
Anthos Therapeutics, Inc.
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
ROXI-CAT-II
Regeneron Pharmaceuticals
ASTER
Anthos Therapeutics, Inc.
CATforCAT
Centre Hospitalier Universitaire de Saint Etienne
CATIQ P3
Quercis Pharma AG
HEM-DOAC
Medical University of Gdansk
HYDRA
Leiden University Medical Center
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
Brigham and Women's Hospital
IPVB and POCs
Tongji Hospital
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Medical University of South Carolina
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
ELEVATE
Prisma Health-Midlands
PREPOSTEROUS
Helsinki University Central Hospital
MVTEP2/SOME2
University Hospital, Brest
EPLLMMRDC
North Sichuan Medical College
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Thunder Bay Regional Health Research Institute
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
University of Zurich
On Dose Efficiency of Modern CT-scanners in Chest Scans
University Hospital Augsburg
CANVAS
Alliance Foundation Trials, LLC.
PAP-UP
Thomas Jefferson University
SOME-RIETE
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
LISSE1
Centre Hospitalier Régional d'Orléans
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
University of Utah
CHIPs-VTE Study in Hospitalized Patients With Lung Cancer
China-Japan Friendship Hospital
PREVENTER
Johns Hopkins University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
The University of Hong Kong
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
ALICAT
Cardiff University
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
VA Greater Los Angeles Healthcare System
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
Bristol-Myers Squibb
PHACS
University of Rochester
SOME
Ottawa Hospital Research Institute
PERI-OP
Ottawa Hospital Research Institute
CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)
Rovi Pharmaceuticals Laboratories
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Ontario Clinical Oncology Group (OCOG)